Session Information
-
NACLC 2019
2019 North American Conference on Lung Cancer
(Chicago, IL, USA): October 10 – 12, 2019
The NACLC 2019 Virtual Meeting will be composed of the PowerPoint slides of the presentations only.Presentation Date(s):- October 10 – 12, 2019
- Total Presentations: 125
-
+
GS06 - Precision Medicine in Advanced Thoracic Tumors
- 08:15 - 09:15
- 10/12/2019
- Location: Imperial Ballroom (B2 Level)
- IASLC CME Accredited
- Type: Invited Speaker Session
- Track:
-
+
GS06.01 - Introduction
08:15 - 08:18 | Presenter: Lecia Sequist
- Abstract
No abstract available for this presentation
-
+
GS06.02 - Treatment of New and Emerging Driver Mutations
08:18 - 08:25 | Presenter: Paul Paik
- Abstract
No abstract available for this presentation
-
+
GS06.03 - Updates in ALK
08:25 - 08:32 | Presenter: Caroline McCoach
- Abstract
No abstract available for this presentation
-
+
GS06.04 - Progression after First Line Osimertinib
08:32 - 08:39 | Presenter: Lecia Sequist
- Abstract
No abstract available for this presentation
-
+
GS06.05 - Clinical Trials in MPM
08:39 - 08:46 | Presenter: Hedy Kindler
- Abstract
No abstract available for this presentation
-
+
GS06.06 - SCLC - Updates
08:46 - 08:52 | Presenter: Anna Farago
- Abstract
No abstract available for this presentation
-
+
GS06.07 - CNS Disease - Systemic Therapy as First Line: From a Radiation Oncology Perspective
08:52 - 09:00 | Presenter: Vinai Gondi
- Abstract
No abstract available for this presentation
-
+
GS06.08 - Panel Discussion
09:00 - 09:15
- Abstract
No abstract available for this presentation
-
+
GS07 - Multidisciplinary Approaches to Diagnosis and Treatment
- 08:15 - 09:15
- 10/12/2019
- Location: Rouge (Lobby Level)
- IASLC CME Accredited
- Type: Invited Speaker Session
- Track:
-
+
GS07.01 - Introduction
08:15 - 08:20 | Presenter: Elizabeth David
- Abstract
No abstract available for this presentation
-
+
GS07.02 - Rebiopsy after Progressive Disease, Pseudoprogression, Adjudication of Site Selection
08:20 - 08:28 | Presenter: Tim Murgu
- Abstract
No abstract available for this presentation
-
+
GS07.03 - Management of Malignant Effusion (TKIs and IO)
08:28 - 08:36 | Presenter: Carla Lamb
- Abstract
No abstract available for this presentation
-
+
GS07.04 - MPR Post Neo-adjuvant IO
08:36 - 08:44 | Presenter: Ignacio Wistuba
- Abstract
No abstract available for this presentation
-
+
GS07.05 - Diagnostic and Management Dilemmas in Synchronous NSCLC
08:44 - 08:52 | Presenter: Elizabeth David
- Abstract
No abstract available for this presentation
-
+
GS07.06 - Ablative Radiation Therapy for Operable Disease
08:52 - 09:00 | Presenter: Megan Daly
- Abstract
No abstract available for this presentation
-
+
GS07.07 - Panel Discussion
09:00 - 09:15
- Abstract
No abstract available for this presentation
-
+
OA02 - Screening and IO Toxicity
- 09:45 - 11:15
- 10/12/2019
- Location: Imperial Ballroom (B2 Level)
- IASLC CME Accredited
- Type: Oral Abstract Session
- Track:
-
+
OA02.01 - Outcomes of Integrating Individualized Tobacco Cessation Counseling in a Lung Cancer Screening Program
09:45 - 09:52 | Presenter: John Pagteilan | Author(s): Matthew Steliga, Patricia Franklin, Claudia Barone, Mollie Meek, Jason Muesse, Nicholas Tingquist
- Abstract
Loading... -
+
OA02.02 - Outcomes of Smoking Cessation Counseling in a Surgical Clinic.
09:52 - 09:59 | Presenter: Nicholas Tingquist | Author(s): Matthew Steliga, Claudia Barone, Patricia Franklin, Jason Muesse, John Pagteilan
- Abstract
Loading... -
+
OA02.03 - CNS Metastasis as Exclusion Criteria in Clinical Trials Involving Extensive-Stage Small Cell Lung Cancer
10:59 - 11:06 | Presenter: Takefumi Komiya | Author(s): Andy Wang
- Abstract
Loading... -
+
OA02.04 - Discussant: Smoking Cessation and Inclusivity in Clinical Trials
10:06 - 10:16 | Author(s): Ticiana Leal
- Abstract
No abstract available for this presentation
-
+
OA02.05 - Clinical-radiomic Models Predict Overall Survival Among Non-small Cell Lung Cancer Patients Treated with Immunotherapy
11:16 - 11:26 | Presenter: Ilke Tunali | Author(s): Yan Tan, Jhanelle E Gray, Steven Eschrich, Albert Guvenis, Robert Gillies, Matthew Schabath
- Abstract
Loading... -
+
OA02.06 - Lung Cancer Screening in Patients With Versus Without a Personal History of Cancer
11:26 - 11:33 | Presenter: M. Patricia Rivera | Author(s): Magda VanDyk, Tina Taylor, Jason Long, Samantha Sites, Caitlin Bearden, Devena Alston-Johnson, Elizabeth Ciociola, Louise Henderson
- Abstract
Loading... -
+
OA02.07 - Low Dose CT Lung Screening in First Responders
10:33 - 10:40 | Presenter: Vershalee Shukla | Author(s): Tyler Tyrlik, Scott Brandman, Michael Peterson-Incorvaia, Kara Kalkbrenner, Jennifer Denogean, Pablo Prichard
- Abstract
Loading... -
+
OA02.08 - Peritumoral and Intratumoral Radiomic Features Identify Aggressive Screen-detected Early-stage Lung Cancers
10:40 - 10:47 | Presenter: Jaileene Perez Morales | Author(s): Ilke Tunali, Olya Stringfield, Steven Eschrich, Yoganand Balagurunathan, Robert Gillies, Matthew Schabath
- Abstract
Loading... -
+
OA02.09 - Multi-Planar Lung Cancer Measurements Provide Improved Accuracy in Clinical Staging
11:47 - 11:54 | Presenter: Erin M. Corsini | Author(s): Girish Shroff, Sonia L. Betancourt, Kyle G. Mitchell, Nicolas Zhou, Tinsu Pan, Gregory Rauch, Mara B. Antonoff, Carol Wu
- Abstract
Loading... -
+
OA02.10 - Discussant: Radiomics, Screening and Imaging
10:54 - 11:04 | Author(s): Sharyn Katz
- Abstract
No abstract available for this presentation
-
+
OA03 - IO Concerns and Targeted Therapies
- 09:45 - 11:15
- 10/12/2019
- Location: Rouge (Lobby Level)
- IASLC CME Accredited
- Type: Oral Abstract Session
- Track:
-
+
OA03.01 - Biomarkers of Autoimmune Toxicity in Metastatic SCLC Patients Receiving PD-1/PDL-1 Targeted Therapy
09:45 - 09:52 | Presenter: Apoorva Tangri | Author(s): Imad Tarhoni, Brendan Gilmore, Mary Fidler, Marta Batus, Philip Bonomi, Jeffrey Borgia
- Abstract
Loading... -
+
OA03.02 - Outcomes of Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC) with Brain Metastases Treated with Pembrolizumab
09:52 - 09:59 | Presenter: Lova Sun | Author(s): Christiana Davis, Melina Marmarelis, Aditi Singh, Abigail Berman, Steven Feigenberg, William Levin, Joshua Bauml, Roger Cohen, Corey Langer, Charu Aggarwal
- Abstract
Loading... -
+
OA03.03 - Multi-institutional Study of Pneumonitis after Treatment with Durvalumab and Chemoradiotherapy for Non-Small Cell Lung Cancer
09:59 - 10:06 | Presenter: Timothy Sita | Author(s): Comron Hassanzadeh, Rohan Savoor, Pamela Samson, Jeffrey Bradley, Michelle Gentile, Michael Roach, Nisha Mohindra, Saiama Waqar, Clifford Robinson, Tim Kruser
- Abstract
Loading... -
+
OA03.04 - Analysis of Patient Microbiome and Its Correlation to Immunotherapy Response and Toxicity in Lung Cancer.
10:06 - 10:13 | Presenter: Jun Zhang | Author(s): Justin Chau, Meeta Yadav, Muhammad Furqan, Nicole Cady, Keri Nace Mercer, Evan Eastman, Taher Abu-Hejleh, Shailesh Shahi, Qun Dai, Yousef Zakharia, Rohan Garje, Carlos Chan, George Weiner, Ashutosh Mangalam
- Abstract
Loading... -
+
OA03.05 - Discussant: Predictors of IO Toxicity
10:13 - 10:23 | Author(s): Kristen Marrone
- Abstract
No abstract available for this presentation
-
+
OA03.06 - Impact of an EGFR-lung Cancer Diagnosis on Quality of Life of Patients: Learnings from Project PRIORITY
10:23 - 10:30 | Presenter: Jill Feldman | Author(s): Upal Basu Roy, Ivy Elkins, Anita Figueras, Teri Kennedy
- Abstract
Loading... -
+
OA03.07 - Evaluating Racial Differences in KRAS-Mutant Non-Small Cell Lung Cancer
10:30 - 10:37 | Presenter: Jacqueline Aredo | Author(s): Sukhmani Padda, Christian Kunder, Summer Han, Heather Wakelee
- Abstract
Loading... -
+
OA03.08 - Clinical Utility of ctDNA Driver Genomic Alterations (GA) Directing Targeted Therapy in Untreated Advanced NSCLC Patients
10:37 - 10:44 | Presenter: Benjamin Besse | Author(s): Laura Mezquita, David Planchard, Miriam Dorta, Mihaela Aldea, Charles Naltet, Virginie Lamberts, Alina-Miruna Grecea, Patricia MARTIN-ROMANO, Frank de Kievit, Cecile Jovelet, Etienne Rouleau, Ludovic Lacroix, Jordi Remon, Pernelle Lavaud, Anas Gazzah, Clive Morris, Karen Howarth, Emma Green, Christophe Massard
- Abstract
Loading... -
+
OA03.09 - Overall Survival in Patients with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: An Update of the GioTag Study
10:44 - 10:51 | Presenter: Christoph Weinlinger | Author(s): Maximilian J. Hochmair, Alessandro Morabito, Desiree Hao, Cheng-Ta Yang, Ross A Soo, James C-H Yang, Rasim Gucalp, Balazs Halmos, Lara Wang, Angela M, Tanja Cufer
- Abstract
Loading... -
+
OA03.10 - Discussant: Targeted Therapies: Partnerships, Inequities, and Best Therapies
10:51 - 11:01 | Author(s): Christine Lovly
- Abstract
No abstract available for this presentation
-
+
GS08 - Closing Plenary
- 11:30 - 12:30
- 10/12/2019
- Location: Imperial Ballroom (B2 Level)
- IASLC CME Accredited
- Type: Invited Speaker Session
- Track:
-
+
GS08.01 - Novel Tumor Biomarkers and Tumor Immune Profiling
11:30 - 11:45 | Presenter: Kurt Schalper
- Abstract
No abstract available for this presentation
-
+
GS08.02 - Microbiome and Implications for Response to IO
11:45 - 12:00 | Presenter: Thomas Gajewski
- Abstract
No abstract available for this presentation
-
+
GS08.03 - Treatment of Oligometastaic Disease Denovo and at Progression with Driver Mutations, on IO or Neither
12:00 - 12:15 | Presenter: Luda Bazhenova | Author(s): Puneeth Iyengar
- Abstract
No abstract available for this presentation
-
+
GS08.04 - Closing Remarks
12:15 - 12:30 | Presenter: Jyoti Patel | Author(s): Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
GS09 - Women in Thoracic Oncology Networking Lunch
- 12:30 - 13:30
- 10/12/2019
- Location: Rouge (Lobby Level)
- IASLC CME Accredited
- Type: Invited Speaker Session
- Track:
-
+
GS09.01 - An Unscripted Life: Using Improvisational Theater Techniques to Help Women in Medicine Claim Power, Collaborate and Communicate
12:30 - 13:10 | Presenter: Katie Watson
- Abstract
No abstract available for this presentation
-
+
GS09.02 - Q&A
13:10 - 13:30
- Abstract
No abstract available for this presentation